Zai Operating Cash Flow Per Share vs Price To Sales Ratio Analysis

ZLAB Stock

USD 27.73 1.18 4.08%

Zai Lab financial indicator trend analysis is more than just analyzing Zai Lab current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zai Lab is a good investment. Please check the relationship between Zai Lab Operating Cash Flow Per Share and its Price To Sales Ratio accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.

Operating Cash Flow Per Share vs Price To Sales Ratio

Operating Cash Flow Per Share vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zai Lab Operating Cash Flow Per Share account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong relationship.

The correlation between Zai Lab's Operating Cash Flow Per Share and Price To Sales Ratio is 0.64. Overlapping area represents the amount of variation of Operating Cash Flow Per Share that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Zai Lab, assuming nothing else is changed. The correlation between historical values of Zai Lab's Operating Cash Flow Per Share and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Cash Flow Per Share of Zai Lab are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Operating Cash Flow Per Share i.e., Zai Lab's Operating Cash Flow Per Share and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.64

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Zai Lab stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Zai Lab sales, a figure that is much harder to manipulate than other Zai Lab multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Zai Lab's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zai Lab current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.At present, Zai Lab's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 1.49, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.

	2021	2022	2023	2024 (projected)
Interest Expense	3.4M	14.6M	16.8M	17.6M
Depreciation And Amortization	12.6M	17.7M	9.0M	6.7M

Interest Expense Depreciation And Amortization

Zai Lab fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Preferred Stock Total Equity	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.12	0.86	1.0	0.92	0.95	0.92	-0.91	-0.8	0.88	0.93	0.96	1.0	0.89	0.81	-0.03	0.84	0.84	0.96	0.85	0.84	0.67	1.0	0.77	0.91	0.83
Other Current Liab	0.12		0.1	0.1	0.19	0.13	0.07	-0.21	-0.16	0.04	0.2	0.07	0.11	-0.09	0.16	0.28	-0.06	0.08	0.13	0.18	-0.02	-0.2	0.12	0.23	-0.04	0.11
Total Current Liabilities	0.86	0.1		0.84	0.98	0.96	0.87	-0.93	-0.97	0.99	0.87	0.89	0.84	0.8	0.81	-0.04	0.88	0.81	0.91	0.86	0.87	0.57	0.86	0.93	0.87	0.96
Total Stockholder Equity	1.0	0.1	0.84		0.91	0.95	0.91	-0.89	-0.78	0.86	0.91	0.95	1.0	0.89	0.78	-0.09	0.84	0.82	0.94	0.81	0.83	0.66	1.0	0.75	0.9	0.81
Other Liab	0.92	0.19	0.98	0.91		0.98	0.89	-0.96	-0.95	0.97	0.92	0.91	0.91	0.8	0.8	0.0	0.85	0.84	0.94	0.88	0.86	0.57	0.92	0.9	0.87	0.94
Net Tangible Assets	0.95	0.13	0.96	0.95	0.98		0.91	-0.93	-0.91	0.96	0.9	0.94	0.95	0.87	0.8	-0.08	0.9	0.82	0.94	0.84	0.87	0.63	0.95	0.9	0.91	0.93
Property Plant And Equipment Net	0.92	0.07	0.87	0.91	0.89	0.91		-0.91	-0.89	0.85	0.93	0.98	0.89	0.94	0.89	-0.09	0.91	0.96	0.97	0.84	0.95	0.73	0.91	0.83	0.97	0.92
Net Debt	-0.91	-0.21	-0.93	-0.89	-0.96	-0.93	-0.91		0.93	-0.9	-0.98	-0.89	-0.89	-0.79	-0.76	-0.02	-0.79	-0.91	-0.95	-0.87	-0.87	-0.59	-0.91	-0.8	-0.86	-0.9
Retained Earnings	-0.8	-0.16	-0.97	-0.78	-0.95	-0.91	-0.89	0.93		-0.92	-0.87	-0.86	-0.77	-0.77	-0.81	0.01	-0.85	-0.88	-0.9	-0.84	-0.89	-0.55	-0.8	-0.92	-0.85	-0.98
Accounts Payable	0.88	0.04	0.99	0.86	0.97	0.96	0.85	-0.9	-0.92		0.85	0.89	0.86	0.8	0.78	-0.07	0.87	0.76	0.89	0.85	0.84	0.58	0.87	0.9	0.87	0.92
Cash	0.93	0.2	0.87	0.91	0.92	0.9	0.93	-0.98	-0.87	0.85		0.91	0.91	0.82	0.77	0.03	0.76	0.93	0.97	0.88	0.88	0.62	0.93	0.73	0.88	0.84
Non Current Assets Total	0.96	0.07	0.89	0.95	0.91	0.94	0.98	-0.89	-0.86	0.89	0.91		0.94	0.95	0.89	-0.09	0.93	0.88	0.97	0.85	0.92	0.75	0.95	0.85	0.97	0.89
Cash And Short Term Investments	1.0	0.11	0.84	1.0	0.91	0.95	0.89	-0.89	-0.77	0.86	0.91	0.94		0.87	0.78	-0.03	0.82	0.81	0.93	0.83	0.81	0.66	1.0	0.74	0.89	0.8
Common Stock Total Equity	0.89	-0.09	0.8	0.89	0.8	0.87	0.94	-0.79	-0.77	0.8	0.82	0.95	0.87		0.77	-0.22	0.94	0.82	0.9	0.73	0.95	0.84	0.88	0.77	0.99	0.83
Common Stock Shares Outstanding	0.81	0.16	0.81	0.78	0.8	0.8	0.89	-0.76	-0.81	0.78	0.77	0.89	0.78	0.77		0.03	0.79	0.84	0.86	0.81	0.76	0.52	0.8	0.83	0.81	0.83
Non Current Liabilities Total	-0.03	0.28	-0.04	-0.09	0.0	-0.08	-0.09	-0.02	0.01	-0.07	0.03	-0.09	-0.03	-0.22	0.03		-0.23	-0.03	-0.04	0.36	-0.17	0.13	-0.03	-0.05	-0.19	-0.09
Capital Surpluse	0.84	-0.06	0.88	0.84	0.85	0.9	0.91	-0.79	-0.85	0.87	0.76	0.93	0.82	0.94	0.79	-0.23		0.78	0.85	0.7	0.91	0.77	0.83	0.9	0.95	0.92
Other Current Assets	0.84	0.08	0.81	0.82	0.84	0.82	0.96	-0.91	-0.88	0.76	0.93	0.88	0.81	0.82	0.84	-0.03	0.78		0.94	0.8	0.89	0.6	0.83	0.73	0.87	0.86
Other Stockholder Equity	0.96	0.13	0.91	0.94	0.94	0.94	0.97	-0.95	-0.9	0.89	0.97	0.97	0.93	0.9	0.86	-0.04	0.85	0.94		0.9	0.93	0.67	0.95	0.82	0.94	0.9
Total Liab	0.85	0.18	0.86	0.81	0.88	0.84	0.84	-0.87	-0.84	0.85	0.88	0.85	0.83	0.73	0.81	0.36	0.7	0.8	0.9		0.79	0.66	0.85	0.77	0.79	0.8
Property Plant And Equipment Gross	0.84	-0.02	0.87	0.83	0.86	0.87	0.95	-0.87	-0.89	0.84	0.88	0.92	0.81	0.95	0.76	-0.17	0.91	0.89	0.93	0.79		0.78	0.83	0.83	0.97	0.91
Preferred Stock Total Equity	0.67	-0.2	0.57	0.66	0.57	0.63	0.73	-0.59	-0.55	0.58	0.62	0.75	0.66	0.84	0.52	0.13	0.77	0.6	0.67	0.66	0.78		0.67	0.55	0.81	0.62
Total Current Assets	1.0	0.12	0.86	1.0	0.92	0.95	0.91	-0.91	-0.8	0.87	0.93	0.95	1.0	0.88	0.8	-0.03	0.83	0.83	0.95	0.85	0.83	0.67		0.76	0.9	0.82
Intangible Assets	0.77	0.23	0.93	0.75	0.9	0.9	0.83	-0.8	-0.92	0.9	0.73	0.85	0.74	0.77	0.83	-0.05	0.9	0.73	0.82	0.77	0.83	0.55	0.76		0.83	0.96
Common Stock	0.91	-0.04	0.87	0.9	0.87	0.91	0.97	-0.86	-0.85	0.87	0.88	0.97	0.89	0.99	0.81	-0.19	0.95	0.87	0.94	0.79	0.97	0.81	0.9	0.83		0.9
Property Plant Equipment	0.83	0.11	0.96	0.81	0.94	0.93	0.92	-0.9	-0.98	0.92	0.84	0.89	0.8	0.83	0.83	-0.09	0.92	0.86	0.9	0.8	0.91	0.62	0.82	0.96	0.9

Click cells to compare fundamentals

Zai Lab Account Relationship Matchups

Zai Lab fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	355.2M	1.3B	1.6B	1.2B	1.0B	754.6M
Other Current Liab	10.3M	24.0M	46.1M	45.5M	58.9M	61.8M
Total Current Liabilities	46.6M	98.0M	192.9M	139.8M	203.1M	213.2M
Total Stockholder Equity	294.7M	1.2B	1.4B	1.0B	796.1M	623.6M
Other Liab	2.9M	16.9M	27.5M	21.4M	24.6M	25.8M
Net Tangible Assets	285.9M	1.2B	1.4B	1.0B	1.2B	1.3B
Property Plant And Equipment Net	36.9M	47.1M	58.3M	78.8M	68.7M	39.8M
Net Debt	(54.2M)	(423.5M)	(948.6M)	(988.1M)	(775M)	(736.3M)
Retained Earnings	(444.7M)	(713.6M)	(1.4B)	(1.9B)	(2.2B)	(2.1B)
Accounts Payable	22.7M	62.6M	126.2M	66.0M	113.0M	118.6M
Cash	75.9M	442.1M	964.1M	1.0B	790.2M	448.6M
Non Current Assets Total	62.7M	81.6M	109.1M	95.8M	96.7M	61.5M
Cash And Short Term Investments	275.9M	1.2B	1.4B	1.0B	806.5M	644.9M
Common Stock Total Equity	3.0K	3.5K	4K	5K	5.8K	3.0K
Common Stock Shares Outstanding	87.8M	77.7M	93.0M	95.8M	96.6M	76.3M
Liabilities And Stockholders Equity	355.2M	1.3B	1.6B	1.2B	1.0B	754.6M
Non Current Liabilities Total	13.9M	30.3M	37.1M	34.7M	37.1M	28.5M
Other Current Assets	6.7M	10.9M	18.0M	35.7M	23.0M	12.4M
Other Stockholder Equity	734.7M	1.9B	2.8B	2.9B	3.0B	1.5B
Total Liab	60.5M	128.3M	230M	174.5M	240.2M	131.0M
Total Current Assets	292.5M	1.2B	1.5B	1.1B	939.6M	693.0M
Accumulated Other Comprehensive Income	4.6M	(14.5M)	(23.6M)	25.7M	37.6M	39.5M
Intangible Assets	8.8M	9.4M	9.7M	8.4M	16.5M	17.3M
Common Stock	3.5K	4.1K	5K	6K	6.9K	4.2K
Property Plant Equipment	36.4M	46.9M	57.3M	77.4M	89.0M	93.4M
Non Currrent Assets Other	510.2K	743K	803K	2.2M	2.3M	2.4M
Other Assets	15.1M	110.1M	26.5M	3.6M	4.1M	3.9M
Long Term Investments	2.4M	1.3M	15.6M	6.4M	9.2M	5.5M
Current Deferred Revenue	2.9M	24.7M	27.5M	21.4M	19.2M	18.3M
Net Invested Capital	301.1M	1.2B	1.4B	1.0B	796.1M	814.3M
Net Working Capital	245.8M	1.1B	1.3B	984.5M	736.5M	759.3M
Short Term Debt	10.8M	10.4M	11.9M	7.1M	14.2M	13.5M
Short Long Term Debt Total	21.8M	18.6M	15.5M	20.4M	15.2M	17.4M
Net Receivables	3.8M	5.2M	54.8M	48.6M	65.3M	68.6M
Short Term Investments	200M	744.7M	445M	0.0	16.3M	15.5M
Inventory	6.0M	13.1M	19.0M	31.6M	44.8M	47.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:

How To Invest In Zai

Details

Is Zai Stock a good investment?

Details

What is Zai Lab's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.80)

Revenue Per Share

3.647

Quarterly Revenue Growth

0.477

Return On Assets

(0.21)

Return On Equity

(0.35)

The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zai Operating Cash Flow Per Share vs Price To Sales Ratio Analysis

Operating Cash Flow Per Share vs Price To Sales Ratio

Operating Cash Flow Per Share vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Operating Cash Flow Per Share

Price To Sales Ratio

Zai Lab fundamental ratios Correlations

Zai Lab Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zai Lab fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Property Plant Equipment	- 0.98	Retained Earnings
Cash	- 0.98	Net Debt
Retained Earnings	- 0.97	Total Current Liabilities
Net Debt	- 0.96	Other Liab
Other Stockholder Equity	- 0.95	Net Debt
Retained Earnings	- 0.95	Other Liab